MSF: J&J must stop blocking generic versions of lifesaving TB drug

J&J’s patent monopoly continues to keep key TB drugs out of reach Johnson & Johnson (J&J) must stop trying to extend its monopoly on tuberculosis (TB) drug bedaquiline in all countries with a high burden of TB, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) ahead of J&J’s annual shareholders’ meeting…